ISIN | CH0461413921 |
---|---|
Valor Number | 46141392 |
Bloomberg Global ID | |
Fund Name | Swisscanto (CH) Index Equity Fund United Kingdom GT GBP |
Fund Provider |
Swisscanto Fondsleitung AG
Zurich E-Mail: fonds@swisscanto.ch |
Fund Provider | Swisscanto Fondsleitung AG |
Representative in Switzerland | |
Distributor(s) | Schweizerische Kantonalbanken |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | The fund charges a transaction fee (contribution towards covering expenses incurred in the sale of assets) |
Investment Strategy *** | Die Anlagen dieses Teilvermögens erfolgen in Anlehnung an den MSCI® United Kingdom Index, welcher von der MORGAN STANLEY CAPITAL INTERNATIONAL INC. (MSCI) fest-gelegt und berechnet wird und darauf ausgelegt ist, die Performance der Mid- und Large Cap Segmente des Marktes des Vereinigten Königreiches (Grossbritannien und Nordirland) zu messen. |
Peculiarities |
Current Price * | 131.98 GBP | 21.11.2024 |
---|---|---|
Previous Price * | 130.88 GBP | 20.11.2024 |
52 Week High * | 135.29 GBP | 17.10.2024 |
52 Week Low * | 116.25 GBP | 29.11.2023 |
NAV * | 131.98 GBP | 21.11.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 141,764,166 | |
Unit/Share Assets *** | 2,097,200 | |
Trading Information SIX |
YTD Performance | +8.88% |
29.12.2023 - 21.11.2024
29.12.2023 21.11.2024 |
---|---|---|
YTD Performance (in CHF) | +13.48% |
29.12.2023 - 21.11.2024
29.12.2023 21.11.2024 |
1 month | -1.70% |
21.10.2024 - 21.11.2024
21.10.2024 21.11.2024 |
3 months | -1.14% |
21.08.2024 - 21.11.2024
21.08.2024 21.11.2024 |
6 months | -1.73% |
21.05.2024 - 21.11.2024
21.05.2024 21.11.2024 |
1 year | +12.70% |
21.11.2023 - 21.11.2024
21.11.2023 21.11.2024 |
2 years | +18.49% |
21.11.2022 - 21.11.2024
21.11.2022 21.11.2024 |
3 years | +27.82% |
22.11.2021 - 21.11.2024
22.11.2021 21.11.2024 |
5 years | +35.40% |
21.11.2019 - 21.11.2024
21.11.2019 21.11.2024 |
Equity Participation Rate in % | 97.75 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
AstraZeneca PLC | 8.99% | |
---|---|---|
Shell PLC | 8.12% | |
HSBC Holdings PLC | 6.77% | |
Unilever PLC | 6.12% | |
RELX PLC | 3.47% | |
BP PLC | 3.20% | |
GSK PLC | 3.02% | |
Rio Tinto PLC Registered Shares | 2.94% | |
Diageo PLC | 2.82% | |
British American Tobacco PLC | 2.74% | |
Last data update | 31.10.2024 |
TER | 0.16% |
---|---|
TER date | 29.09.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.30% |
Ongoing Charges *** | 0.16% |
SRRI ***
|
|
SRRI date *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |